Surat, Feb 27: Anupam Rasayan India Ltd, a provider of custom synthesis and specialty chemicals, today announced completion of 100% acquisition of equity stake in Jayhawk Fine Chemicals Corporation (“Jayhawk”), part of the CABB group which is a U.S.-based specialty chemical company.
The acquisition deal has been made for a consideration of US$150 million through its wholly owned subsidiary, Doriath S.à r.l.
The total purchase consideration has been financed through:
– US$109 million via issuance of Class B non-voting shares issued by Doriath S.à r.l.
– US$41 million via debt
The acquisition is financed through the following sources:
– US$129 million funded by Altis XII Pte. Ltd. (Affiliate of funds managed by Oaktree Capital Management, L.P (“Oaktree”), a leader among global investment managers specializing in alternative investments with US$223bn under management as of December 31, 2025)
– US$21 million from Axis Bank
Jayhawk would be fully consolidated with Anupam and the acquisition shall be EPS accretive, the company said in a statement.
Founded in 1941 and headquartered in Galena, Kansas, USA, Jayhawk is part of the CABB Group and is engaged in custom manufacturing of advanced intermediates, active ingredients, and high- performance materials.
“We are pleased to announce the successful closing of the acquisition of Jayhawk. This transaction marks a significant milestone in our long-term strategy of building a differentiated, innovation-led global specialty chemicals platform,” said Anand Desai, Managing Director, Anupam Rasayan India Ltd.ncial advisor to the CABB Group.
